MicroRNA-142 reduces monoamine oxidase a expression and activity in neuronal cells by downregulating SIRT1

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Chaudhuri, Amrita Datta ^a   Yelamanchili, Sowmya V ^a   Fox, Howard S ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; MESSENGER RNA; MICRORNA; MICRORNA 142; MICRORNA 142 3P; MICRORNA 142 5P; SIRTUIN 1; UNCLASSIFIED DRUG; AMINE OXIDASE (FLAVIN CONTAINING); MIRN142 MICRORNA, HUMAN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FETUS; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE TARGETING; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAOA GENE; MICROARRAY ANALYSIS; MOLECULAR CLONING; NERVE CELL CULTURE; NEUROBLASTOMA CELL; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIRT1 GENE; STABLE EXPRESSION; BIOLOGICAL MODEL; CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION; GENETICS; METABOLISM; NERVE CELL; RNA INTERFERENCE;

CELL LINE; ENZYME ACTIVATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; MONOAMINE OXIDASE; NEURONS; RNA INTERFERENCE; RNA, MESSENGER; SIRTUIN 1;

EID: 84893157968     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079579     Document Type: Article

References (39)

1. Sun AX, Crabtree GR, Yoo AS (2013) MicroRNAs: regulators of neuronal fate. Current Opinion in Cell Biology 25: 215-221.
2. Salta E, De Strooper B (2012) Non-coding RNAs with essential roles in neurodegenerative disorders. The Lancet Neurology 11: 189-200.
3. Zhou L, Pupo GM, Gupta P, Liu B, Tran SL, et al. (2012) A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration. BMC Genomics 13: 677.
4. Pacifici M, Delbue S, Ferrante P, Jeansonne D, Kadri F, et al. (2013) Cerebrospinal fluid miRNA profile in HIV-encephalitis. J Cell Physiol 228: 1070-1075.
5. Winkler JM, Chaudhuri AD, Fox HS (2012) Translating the Brain Transcriptome in NeuroAIDS: From Non-human Primates to Humans. J Neuroimmune Pharmacol 7: 372-379.
6. Yelamanchili SV, Chaudhuri AD, Chen LN, Xiong H, Fox HS (2010) MicroRNA-21 dysregulates the expression of MEF2C in neurons in monkey and human SIV/HIV neurological disease. Cell Death and Dis 1: e77.
7. Noorbakhsh F, Ramachandran R, Barsby N, Ellestad KK, LeBlanc A, et al. (2010) MicroRNA profiling reveals new aspects of HIV neurodegeneration: caspase-6 regulates astrocyte survival. FASEB J 24: 1799-1812.
8. Chaudhuri AD, Yelamanchili SV, Marcondes MC, Fox HS (2013) Upregulation of microRNA-142 in simian immunodeficiency virus encephalitis leads to repression of sirtuin1. FASEB J.
9. Kaul M (2009) HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches. Curr Opin Neurol 22: 315-320.
10. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799. (Pubitemid 350059308)
11. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, et al. (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17: 3-16.
12. Gersten M, Alirezaei M, Marcondes MC, Flynn C, Ravasi T, et al. (2009) An integrated systems analysis implicates EGR1 downregulation in simian immunodeficiency virus encephalitis-induced neural dysfunction. J Neurosci 29: 12467-12476.
13. Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86. (Pubitemid 38055775)
14. Bissels U, Wild S, Tomiuk S, Hafner M, Scheel H, et al. (2011) Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells. Stem Cells 29: 847-857.
15. Jin HL, Kim JS, Kim YJ, Kim SJ, Broxmeyer HE, et al. (2012) Dynamic expression of specific miRNAs during erythroid differentiation of human embryonic stem cells. Mol Cells 34: 177-183.
16. Nishiyama T, Kaneda R, Ono T, Tohyama S, Hashimoto H, et al. (2012) miR-142-3p is essential for hematopoiesis and affects cardiac cell fate in zebrafish. Biochem Biophys Res Commun 425: 755-761.
17. Wu D, Raafat M, Pak E, Hammond S, Murashov AK (2011) MicroRNA machinery responds to peripheral nerve lesion in an injury-regulated pattern. Neuroscience 190: 386-397.
18. Eipper-Mains JE, Kiraly DD, Palakodeti D, Mains RE, Eipper BA, et al. (2011) microRNA-Seq reveals cocaine-regulated expression of striatal microRNAs. RNA 17: 1529-1543.
19. Tobon KE, Chang D, Kuzhikandathil EV (2012) MicroRNA 142-3p mediates post-transcriptional regulation of D1 dopamine receptor expression. PLoS One 7: e49288.
20. Shende VR, Goldrick MM, Ramani S, Earnest DJ (2011) Expression and rhythmic modulation of circulating microRNAs targeting the clock gene Bmal1 in mice. PLoS One 6: e22586.
21. Tan X, Zhang P, Zhou L, Yin B, Pan H, et al. (2012) Clock-controlled mir-142-3p can target its activator, Bmal1. BMC Mol Biol 13: 27.
22. Shende VR, Neuendorff N, Earnest DJ (2013) Role of miR-142-3p in the Post-Transcriptional Regulation of the Clock Gene Bmal1 in the Mouse SCN. PLoS One 8: e65300.
23. Libert S, Pointer K, Bell EL, Das A, Cohen DE, et al. (2011) SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell 147: 1459-1472.
24. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
25. Wang X, McManus M (2009) Lentivirus production. J Vis Exp.
26. Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, et al. (2004) Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303: 2011-2015. (Pubitemid 38393275)
27. Naoi M, Maruyama W, Inaba-Hasegawa K, Akao Y (2011) Type A monoamine oxidase regulates life and death of neurons in neurodegeneration and neuroprotection. Int Rev Neurobiol 100: 85-106.
28. Bortolato M, Chen K, Shih JC (2008) Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 60: 1527-1533.
29. Alia-Klein N, Goldstein RZ, Kriplani A, Logan J, Tomasi D, et al. (2008) Brain monoamine oxidase A activity predicts trait aggression. J Neurosci 28: 5099-5104.
30. Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, et al. (2006) Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 63: 1209-1216. (Pubitemid 44708079)
31. Schulze TG, Muller DJ, Krauss H, Scherk H, Ohlraun S, et al. (2000) Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 96: 801-803.
32. Yu YW, Tsai SJ, Hong CJ, Chen TJ, Chen MC, et al. (2005) Association study of a monoamine oxidase a gene promoter polymorphism with major depressive disorder and antidepressant response. Neuropsychopharmacology 30: 1719-1723. (Pubitemid 43086029)
33. Scheller C, Arendt G, Nolting T, Antke C, Sopper S, et al. (2010) Increased dopaminergic neurotransmission in therapy-naive asymptomatic HIV patients is not associated with adaptive changes at the dopaminergic synapses. J Neural Transm 117: 699-705.
34. Kumar AM, Fernandez JB, Singer EJ, Commins D, Waldrop-Valverde D, et al. (2009) Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J Neurovirol 15: 257-274.
35. Gelman BB, Spencer JA, Holzer CE, 3rd, Soukup VM (2006) Abnormal striatal dopaminergic synapses in National NeuroAIDS Tissue Consortium subjects with HIV encephalitis. J Neuroimmune Pharmacol 1: 410-420. (Pubitemid 44786674)
36. Gaskill PJ, Carvallo L, Eugenin EA, Berman JW (2012) Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse. J Neuroinflammation 9: 203.
37. Gaskill PJ, Calderon TM, Luers AJ, Eugenin EA, Javitch JA, et al. (2009) Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse. Am J Pathol 175: 1148-1159.
38. Gaskill PJ, Calderon TM, Coley JS, Berman JW (2013) Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND. J Neuroimmune Pharmacol 8: 621-642.
39. Chaitidis P, Billett EE, O'Donnell VB, Fajardo AB, Fitzgerald J, et al. (2004) Th2 response of human peripheral monocytes involves isoform-specific induction of monoamine oxidase-A. J Immunol 173: 4821-4827. (Pubitemid 39387762)